Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2026-02-28 @ 7:10 PM
Study NCT ID:
NCT05917951
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2022-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-02
First Submit QC Date:
None
Study First Post Date:
2023-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-28
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL